LPL Financial’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Buy |
31,462
+9,099
| +41% | +$102K | ﹤0.01% | 4557 |
|
|
2025
Q1 | $127K | Buy |
22,363
+3,434
| +18% | +$19.6K | ﹤0.01% | 4858 |
|
|
2024
Q4 | $186K | Sell |
18,929
-4,988
| -21% | -$49K | ﹤0.01% | 4718 |
|
|
2024
Q3 | $195K | Buy |
23,917
+9,124
| +62% | +$74.4K | ﹤0.01% | 4630 |
|
|
2024
Q2 | $198K | Buy |
14,793
+590
| +4% | +$7.89K | ﹤0.01% | 4476 |
|
|
2024
Q1 | $659K | Buy |
14,203
+2,279
| +19% | +$106K | ﹤0.01% | 3507 |
|
|
2023
Q4 | $806K | Buy |
11,924
+1,675
| +16% | +$113K | ﹤0.01% | 3220 |
|
|
2023
Q3 | $742K | Buy |
10,249
+3,184
| +45% | +$231K | ﹤0.01% | 3142 |
|
|
2023
Q2 | $526K | Buy |
7,065
+1,851
| +36% | +$138K | ﹤0.01% | 3374 |
|
|
2023
Q1 | $277K | Buy |
5,214
+619
| +13% | +$32.9K | ﹤0.01% | 3779 |
|
|
2022
Q4 | $311K | Buy |
4,595
+211
| +5% | +$14.3K | ﹤0.01% | 3604 |
|
|
2022
Q3 | $547K | Buy |
4,384
+1,762
| +67% | +$220K | ﹤0.01% | 3055 |
|
|
2022
Q2 | $250K | Buy |
+2,622
| New | +$250K | ﹤0.01% | 3748 |
|
|
2022
Q1 | – | Sell |
-349
| Closed | -$116K | – | 4226 |
|
|
2021
Q4 | $116K | Sell |
349
-107
| -23% | -$35.6K | ﹤0.01% | 4105 |
|
|
2021
Q3 | $212K | Buy |
+456
| New | +$212K | ﹤0.01% | 3910 |
|